Share 'BioMarin Discontinues Clinical Development of Drisapersen'
Today is June 1 and I know many of us feel like 2016 has beat up this community already. With every small victory, we face another major setback.
As you have heard by now, BioMarin announced that they were discontinuing the clinical development of drisapersen after interactions with both the FDA and EMA. We are heartbroken.
To say Duchenne is difficult is a gross understatement. Until you h…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this